HYPHEN BioMed
TaiwanFrance16 products registeredDec 22, 2015 – Dec 25, 2023
VerifiedTFDA · Taiwan Food and Drug Administration registry
16
Total products
16
Product types
16
Active products
Dec 2023
Latest registration
Company details
- Address
- 155 rue d'Eragny, 95000 Neuville sur Oise, France
Regulatory footprint
Search HYPHEN BioMed across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
"Haifeng Biomedical" activates factor 10 direct inhibitors
Class 2
Dec 25, 2023
"Haifong Biomedical" Edoxaban correction solution group
Class 2
Jun 15, 2021
"Haifeng Biomedical" Edoxaban quality control liquid group
Class 2
May 20, 2021
"Haifong Biomedical" Rivaroxaban correction solution group
Class 2
Feb 23, 2021
"Haifeng Biomedical" Dabigatran quality control liquid
Class 2
Feb 08, 2021
Most popular products
Products with most registrations
"Haifeng Biomedical" activates factor 10 direct inhibitors
1 registrations
"Haifong Biomedical" Edoxaban correction solution group
1 registrations
"Haifeng Biomedical" Edoxaban quality control liquid group
1 registrations
"Haifong Biomedical" Rivaroxaban correction solution group
1 registrations
"Haifeng Biomedical" Dabigatran quality control liquid
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
"Haifeng Biomedical" activates factor 10 direct inhibitors
Registered: Dec 25, 2023 • Expires: Dec 25, 2028
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
"Haifong Biomedical" Edoxaban correction solution group
Registered: Jun 15, 2021 • Expires: Jun 15, 2026
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
"Haifeng Biomedical" Edoxaban quality control liquid group
Registered: May 20, 2021 • Expires: May 20, 2026
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
"Haifong Biomedical" Rivaroxaban correction solution group
Registered: Feb 23, 2021 • Expires: Feb 23, 2026
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
"Haifeng Biomedical" Dabigatran quality control liquid
Registered: Feb 08, 2021 • Expires: Feb 08, 2026
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
"Haifeng Biomedical" Rivaroxaban quality control liquid group
Registered: Jan 06, 2021 • Expires: Jan 06, 2026
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
"Haifeng Biomedicine" Dabigatran correction solution
Registered: Nov 09, 2020 • Expires: Nov 09, 2025
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
“HYPHEN”LA CONTROL PLASMA KIT
Registered: Oct 03, 2019 • Expires: Oct 03, 2024
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
"Sysmex" Revohem Collagen
Registered: Jan 10, 2019 • Expires: Jan 10, 2029
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
“Sysmex” Revohem Ristocetin
Registered: Dec 19, 2018 • Expires: Dec 19, 2028
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
“Sysmex” Revohem ADP
Registered: Nov 06, 2018 • Expires: Nov 06, 2028
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
BIOPHEN APIXABAN CALIBRATOR LOW
Registered: Mar 17, 2016 • Expires: Mar 17, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
BIOPHEN APIXABAN CALIBRATOR
Registered: Mar 17, 2016 • Expires: Mar 17, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
BIOPHEN APIXABAN CONTROL
Registered: Mar 15, 2016 • Expires: Mar 15, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
BIOPHEN APIXABAN CONTROL LOW
Registered: Mar 15, 2016 • Expires: Mar 15, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- SYSMEX TAIWAN CO., LTD.
Sea Separation Medical RIVAROXABAN correction solution and quality control liquid
Registered: Dec 22, 2015 • Expires: Dec 22, 2025
- Risk Class
- Class 2
- AR
- SYSMEX TAIWAN CO., LTD.
About this profile
Explore comprehensive manufacturer profile for HYPHEN BioMed based in France through Pure Global AI's free Taiwan medical device database. This manufacturer has 16 products registered in Taiwan across 16 unique product categories. Their regulatory history spans from Dec 22, 2015 to Dec 25, 2023.
This page provides detailed insights including 5 recent product registrations, 5 most popular products with "Haifeng Biomedical" activates factor 10 direct inhibitors having 1 registrations, and 1 authorized representatives including SYSMEX TAIWAN CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.